Sutro Biopharma
STRO
$3.81
Share price
1.78%
Change (1 day)
-16.88%
Change (1 year)
Categories
Sutro Biopharma (STRO) - Cash on Hand
Cash on Hand as of December 2023 : $0.37 B
According to Sutro Biopharma's latest financial reports the company has $0.37 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sutro Biopharma - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.33 B | 68.92% |
| 2021-12-31 | $0.19 B | -46.23% |
| 2020-12-31 | $0.36 B | 212.34% |
| 2019-12-31 | $0.11 B | -42.36% |
| 2018-12-31 | $0.20 B | 828.66% |
| 2017-12-31 | $22.02 M | -53.66% |
| 2016-12-31 | $47.52 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -74.47% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -94.46% | 🇺🇸 USA |